Your browser doesn't support javascript.
loading
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.
Périssé, André R S; Smeaton, Laura; Chen, Yun; La Rosa, Alberto; Walawander, Ann; Nair, Apsara; Grinsztejn, Beatriz; Santos, Breno; Kanyama, Cecilia; Hakim, James; Nyirenda, Mulinda; Kumarasamy, Nagalingeswaran; Lalloo, Umesh G; Flanigan, Timothy; Campbell, Thomas B; Hughes, Michael D.
Afiliación
  • Périssé AR; Departamento de Ciências Biológicas, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Smeaton L; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • Chen Y; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America.
  • La Rosa A; Asociacion Civil Impacta Salud y Educacion - Barranco, Lima, Peru.
  • Walawander A; Frontier Science and Technology Research Foundation, Amherst, New York, United States of America.
  • Nair A; Frontier Science and Technology Research Foundation, Amherst, New York, United States of America.
  • Grinsztejn B; Evandro Chagas Clinical Research Institute, Fiocruz, Rio de Janeiro, Brazil.
  • Santos B; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
  • Kanyama C; Kamuzu Central Hospital, Lilongwe, Malawi.
  • Hakim J; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
  • Nyirenda M; Mulinda Nyirenda, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Kumarasamy N; YRG Centre for AIDS Research and Education, Chennai, India.
  • Lalloo UG; Nelson R. Mandela School of Medicine, Durban, South Africa.
  • Flanigan T; Brown Medical School, Providence, Rhode Island, United States of America.
  • Campbell TB; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
  • Hughes MD; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.
PLoS One ; 8(12): e83643, 2013.
Article en En | MEDLINE | ID: mdl-24391801
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / VIH-1 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2013 Tipo del documento: Article País de afiliación: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / VIH-1 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2013 Tipo del documento: Article País de afiliación: Brasil